No-Reflow Phenomenon
Showing 1 - 25 of >10,000
ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, No-Reflow Phenomenon Trial in Tomsk (Standard therapy,
Active, not recruiting
- ST Elevation Myocardial Infarction
- +2 more
- Standard therapy
- +3 more
-
Tomsk, Tomsk Region, Russian FederationCardiology Research Institute, Tomsk NRMC
Oct 31, 2022
No-Reflow Phenomenon Trial (Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI)
Not yet recruiting
- No-Reflow Phenomenon
- Alpha Lipoic Acid plus the standard care for post-PCI MI
- The standard care for post-PCI MI
- (no location specified)
Apr 29, 2022
STEMI, Large Thrombus Burden, No-Reflow Phenomenon Trial (Upfront preparation of microcirculation to minimize risks of no-reflow
Not yet recruiting
- STEMI
- +2 more
- Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury
- (no location specified)
May 26, 2022
Coronary Microvascular Obstruction in PCI
Recruiting
- Myocardial Infarction
- No-Reflow Phenomenon
- different variants of SNPs that may be associated with the coronary microvascular obstruction development
-
Nizhny Novgorod, Nizhny Novgorod Region, Russian Federation
- +1 more
Nov 18, 2022
No-Reflow Phenomenon, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Seoul (Nicorandil, Placebo)
Not yet recruiting
- No-Reflow Phenomenon
- +2 more
- Nicorandil
- Placebo
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Aug 16, 2022
Acute Coronary Syndrome, No-Reflow Phenomenon, Normotensive Trial in Karachi (Adrenaline, Adenosine)
Completed
- Acute Coronary Syndrome
- +2 more
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases
May 20, 2021
No-Reflow Phenomenon Trial (1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol)
Not yet recruiting
- No-Reflow Phenomenon
- 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S
- (no location specified)
Apr 13, 2021
Mean Platelet Volume and STEMI Clinical Risk Scores in
Recruiting
- No-Reflow Phenomenon
- Mean platelet volume, lymphocyte number, STEMI clinical risk scores
-
Assiut, EgyptAssiut university hospital
Mar 2, 2021
CHA2DS2-VASc Score asPredictor of Thrombus Burden and Clinical
Not yet recruiting
- STEMI
- primary percutaneous coronary intervention
- (no location specified)
Sep 24, 2020
In-hospital and Short-term Clinical Outcomes in STEMI Patients
Not yet recruiting
- STEMI
-
Assiut, EgyptAbdelrahman Ragab
Nov 3, 2023
No Reflow Phenomenon Incidence and Predictors
Completed
- No Reflow Phenomenon
- STEMI
- No intervention as observational study
-
Cottingham, East Yorkshire, United KingdomCastle Hill Hospital (Hull and east Yorkshire Hospitals NHS Trus
Jul 26, 2019
ST Segment Elevation Myocardial Infarction, Coronary Slow Flow Phenomenon Trial in ShangHai (Alprostadil, Nitroglycerin)
Completed
- ST Segment Elevation Myocardial Infarction
- Coronary Slow Flow Phenomenon
-
ShangHai, ChinaRen Ji Hospital Afflited to School of Medicine, Shanghai Jiao To
Mar 11, 2020
Predictor of No-reflow in Diabetic Patients
Not yet recruiting
- Acute Myocardial Infarction (AMI)
- 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S
- (no location specified)
Apr 7, 2021
Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder Trial in Australia (Intra-arterial tenecteplase injection at
Not yet recruiting
- Ischemic Stroke, Acute
- +3 more
- Intra-arterial tenecteplase injection at the completion of thrombectomy
- Placebo
-
Adelaide, Australia
- +11 more
May 26, 2023
Acute Ischemic Stroke Trial in Tianjin (Intra-Arterial TNK and Albumin, Intra-Arterial TNK, Intra-Arterial Albumin)
Recruiting
- Acute Ischemic Stroke
- Intra-Arterial TNK and Albumin
- +3 more
-
Tianjin, Tianjin, ChinaTianjin Huanhu Hospital
Oct 27, 2023
STEMI - ST Elevation Myocardial Infarction Trial in Isehara (Excimer laser catheter)
Terminated
- STEMI - ST Elevation Myocardial Infarction
- Excimer laser catheter
-
Isehara, Kanagawa, JapanTokai University School of Medicine
Sep 29, 2022
STEMI Trial (PPCI in heavy thrombus burden STEMI patients)
Not yet recruiting
- STEMI
- PPCI in heavy thrombus burden STEMI patients
- (no location specified)
Mar 30, 2023
Cardiac Ischemia, Acute Coronary Syndrome Trial in Daugavpils (PCI)
Recruiting
- Cardiac Ischemia
- Acute Coronary Syndrome
- PCI
-
Daugavpils, LatviaDaugavpils Regional Hospital
Apr 25, 2022
Coronary Artery Disease Trial in Helwan (Colchicine 0.5 MG Oral Tablet, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Colchicine 0.5 MG Oral Tablet
- Placebo
-
Helwan, Cairo, EgyptHelwan University Hospital
Feb 13, 2023
Coronary Thrombosis Trial (Primary Percutaneous coronary angiography)
Not yet recruiting
- Coronary Thrombosis
- Primary Percutaneous coronary angiography
- (no location specified)
Dec 3, 2022
ST Segment Elevation Myocardial Infarction
Completed
- Factor XIII Deficiency
- +3 more
-
Padua, PD, ItalyUniversity of Padua, Cardiology Clinic
May 18, 2022
Coronary Artery Disease, Chronic Renal Failure Trial in Madrid (Percutaneous coronary intervention (PCI))
Recruiting
- Coronary Artery Disease
- Chronic Renal Failure
- Percutaneous coronary intervention (PCI)
-
Madrid, SpainLa Paz University Hospital
Apr 25, 2022
Intravascular ULTRAsound-Guided PCI in ST-Elevation Myocardial
Not yet recruiting
- STEMI
- +2 more
- IVUS imaging for primary PCI guidance
- (no location specified)
Jul 25, 2023
Post Stenting Balloon Dilatation on Coronary Microcirculation in
Completed
- ST-elevation Myocardial Infarction (STEMI)
-
Basildon, Essex, United KingdomThe Essex Cardiothoracic Centre
Aug 31, 2021
Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)
Active, not recruiting
- Coronary Microvascular Dysfunction
- Bivalirudin
- standard heparin
-
Beijing, Beijing, ChinaPeking university first hospital
Aug 1, 2023